EUVIMEDEUVIMED entdecken
Crossref

Systematic Analysis of Homologous Recombination Deficiency Testing in Ovarian Cancer—Development of Recommendations for Optimal Assay Performance

Marcel Romey, Fiona Rodepeter, Akira Hattesohl, Kristin Kaiser, Julia Teply-Szymanski, Florian Heitz, Annette Staebler, Violeta Serra, Albert Grass, Frederik Marmé, Kirsten M Timms, Philipp Harter und 4 weitere

Modern Pathology · 2024-04 · 37 (4) · 100445

DOI: 10.1016/j.modpat.2024.100445 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2024-04. Verfasst von Marcel Romey und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, Philipps-University Marburg, Marburg University Hospital, and University Cancer Center Frankfurt-Marburg, Marburg, Germany. Hauptthemen laut MEDLINE: BRCA1 Protein, Ovarian Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: European Commission, Myriad Genetics, Bundesministerium für Bildung und Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA1 ProteinOvarian NeoplasmsHumansFemaleMutationHomologous RecombinationBRCA2 ProteinGenomic Instability

Stichwörter der Autor:innen

BRCAhistologyhomologous recombination deficiencyovarian cancer

Substanzen

BRCA1 protein, humanBRCA1 ProteinBRCA2 protein, humanBRCA2 Protein

Autor:innen und Institutionen

  • Institute of Pathology, Philipps-University Marburg, Marburg University Hospital, and University Cancer Center Frankfurt-Marburg, Marburg, Germany.
  • Myriad Genetics, Salt Lake City, Utah.
  • Department of Gynecology and Gynecologic Oncology, Ev. Kliniken Essen-Mitte, Essen, Germany; Department of Gynecology with the Centre of Oncologic Surgery Charite Campus, Virchow Klinikum, Charité Universitätsmedizin Be…
  • Institute of Pathology and Neuropathology, Tübingen University Hospital, Tubingen, Germany.
  • Vall d'Hebron Institute of Oncology, Barcelona, Spain.
  • Medical Faculty Mannheim, Department of Obstetrics and Gynaecology, Heidelberg University, University Hospital Mannheim, Mannheim, Germany.

Förderung

  • European Commission
  • Myriad Genetics
  • Bundesministerium für Bildung und Forschung

Zitieren

APA

Romey, M., Rodepeter, F., Hattesohl, A., Kaiser, K., Teply-Szymanski, J., Heitz, F., Staebler, A., Serra, V., Grass, A., Marmé, F., Timms, K. M., Harter, P., Llop-Guevara, A., Kommoss, S., Boekhoff, J., & Denkert, C. (2024). Systematic Analysis of Homologous Recombination Deficiency Testing in Ovarian Cancer—Development of Recommendations for Optimal Assay Performance. Modern Pathology, 37(4), 100445. https://doi.org/10.1016/j.modpat.2024.100445

Vancouver

Romey M, Rodepeter F, Hattesohl A, Kaiser K, Teply-Szymanski J, Heitz F, et al. Systematic Analysis of Homologous Recombination Deficiency Testing in Ovarian Cancer—Development of Recommendations for Optimal Assay Performance. Modern Pathology. 2024;37(4):100445. doi:10.1016/j.modpat.2024.100445

BibTeX
@article{Romey2024,
  author = {Romey, Marcel and Rodepeter, Fiona and Hattesohl, Akira and Kaiser, Kristin and Teply-Szymanski, Julia and Heitz, Florian and Staebler, Annette and Serra, Violeta and Grass, Albert and Marmé, Frederik and Timms, Kirsten M and Harter, Philipp and Llop-Guevara, Alba and Kommoss, Stefan and Boekhoff, Jelena and Denkert, Carsten},
  title = {Systematic Analysis of Homologous Recombination Deficiency Testing in Ovarian Cancer—Development of Recommendations for Optimal Assay Performance},
  journal = {Modern Pathology},
  year = {2024},
  volume = {37},
  number = {4},
  pages = {100445},
  doi = {10.1016/j.modpat.2024.100445}
}
Kostenlos starten →